Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

UCLA researchers in collaboration with Department of Physiology, Anatomy & Genetics researchers have identified a biomarker for increased risk of early mortality in patients with heart failure. Associate Professor Neil Herring is senior author.

A UCLA-led study in collaboration with Harvard and Oxford University researchers has revealed a new way to predict which patients with "stable" heart failure - those who have heart injury but do not require hospitalisation - have a higher risk of dying within one to three years.

Although people with stable heart failure have similar characteristics, some have rapid disease progression while others remain stable. The research shows that patients who have higher levels of neuropeptide Y, a molecule released by the nervous system, are 10 times more likely to die within one to three years than those with lower levels of neuropeptides.

Read more (Department of Physiology, Anatomy & Genetics)